Singapore markets closed

Banco Bradesco S.A. (BBD)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
2.85000.0000 (0.00%)
At close: 01:00PM EST
2.8600 +0.01 (+0.35%)
After hours: 04:22PM EST
Full screen
Trade prices are not sourced from all markets
Previous close2.8500
Open2.8700
Bid0.0000 x 1800
Ask0.0000 x 36100
Day's range2.8200 - 2.9000
52-week range2.7200 - 4.7400
Volume18,793,740
Avg. volume40,509,706
Market cap30.377B
Beta (5Y monthly)1.04
PE ratio (TTM)6.48
EPS (TTM)0.4400
Earnings dateN/A
Forward dividend & yield0.08 (2.78%)
Ex-dividend date02 Dec 2022
1y target est4.35
  • Motley Fool

    Why Shares of Banco Santander Brasil, Banco Bradesco, and Itau Unibanco Holding Are Rising Today

    Shares of several Brazilian banks (and Brazilian stocks in general) rose today after results for the first round of the country's presidential election were reported. Shares of Banco Santander Brasil (NYSE: BSBR) were up roughly 9.2% as of 2:01 p.m. ET. Banco Bradesco (NYSE: BBD) climbed 10.2%, and Itau Unibanco Holding (NYSE: ITUB) traded nearly 10% higher as well.

  • Reuters SG

    Deals of the day-Mergers and acquisitions

    ** Fintech Bitcoin Depot plans to list in the United States by merging with blank check company GSR II Meteora Acquisition Corp in a deal valued at $885 million, the companies said. ** Global shipping container suppliers China International Marine Containers and Maersk Container Industry in a joint statement said they have abandoned a merger plan, citing significant regulatory challenges. ** Brazilian lender Banco Bradesco SA said its subsidiary Bradescard has agreed to acquire Mexico's Ictineo Plataforma SA in a bid to offer digital accounts in Latin America's second-largest economy.

  • Reuters

    Exclusive: UnitedHealth struggling to sell Brazilian unit Amil - sources

    UnitedHealth Group Inc, the top U.S. healthcare company by market capitalization, is struggling to sell Brazilian unit Amil due to antitrust issues and growing losses from individual health plans, according to four people with knowledge of the matter. After studying ways to divest Amil 10 years after acquiring it, UnitedHealth decided last month to suspend the sale process, the sources said, asking for anonymity because the discussions were private. UnitedHealth had agreed to pay acquirers for Amil's loss-making units and lose money on the sale of the whole company, but did not receive an attractive proposal, the sources added.